Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB)

Historical Holders from Q2 2018 to Q1 2023

Type / Class
Equity / Common Stock, $0.00001 par value per share
Symbol
CLRB on Nasdaq
Shares outstanding
75,482,273
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rosalind Advisors, Inc. 9.9% $3,063,825 7,472,745 Rosalind Advisors, Inc. 31 Dec 2024
ADAR1 Capital Management, LLC 0.1% 2,962 ADAR1 Capital Management, LLC 30 Jun 2025

Institutional Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2023 Q1 5 $4 $0 80% 1
2022 Q3 5 $1,000 -$1,499,014 20,000% 1
2022 Q2 3,714,697 $1,499,000 -$97,836 40.32% 22
2022 Q1 6,819,353 $4,688,000 +$178,824 68.78% 27
2021 Q4 6,591,438 $4,376,000 -$753,164 66.42% 35
2021 Q3 7,320,806 $6,772,000 -$6,047,174 92.5% 36
2021 Q2 12,486,174 $14,874,276 -$4,685,189 118.98% 42
2021 Q1 15,046,405 $24,214,357 -$5,842,529 160.9% 41
2020 Q4 17,679,705 $36,895,000 +$23,156,863 208.01% 38
2020 Q3 3,452,402 $4,282,000 +$543,521 124.02% 19
2020 Q2 3,004,861 $3,848,000 +$1,971,093 128.26% 20
2020 Q1 1,465,638 $1,935,000 +$221,919 130.46% 14
2019 Q4 1,295,959 $2,917,000 -$7,988 225.12% 9
2019 Q3 1,257,058 $2,515,054 -$117,191 200% 10
2019 Q2 1,985,734 $4,329,059 +$2,305,178 218.04% 11
2019 Q1 246,868 $581,063 -$32,865 235.43% 9
2018 Q4 262,671 $407,000 +$89,335 155.34% 9
2018 Q3 203,047 $611,000 +$566,997 300.97% 9
2018 Q2 72,383 $44,000 +$44,002 60.79% 1